Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study.
J Eimer, J Vesterbacka, A-K Svensson, B Stojanovic, C Wagrell, A Sönnerborg, P Nowak
Author Information
- J Eimer: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden. ORCID
- J Vesterbacka: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- A-K Svensson: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- B Stojanovic: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- C Wagrell: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- A Sönnerborg: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- P Nowak: From the, Unit of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
No abstract text available.
- Clin Ther. 2017 Aug;39(8):1600-1617
[PMID: 28716293]
- JAMA. 2020 Apr 28;323(16):1574-1581
[PMID: 32250385]
- Eur J Intern Med. 2020 Jun;76:31-35
[PMID: 32405160]
- Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
[PMID: 32350134]
- Crit Care Med. 2011 Feb;39(2):371-9
[PMID: 20959786]
- Cell. 2020 May 28;181(5):1036-1045.e9
[PMID: 32416070]
- Eur Respir J. 2020 Jun 18;55(6):
[PMID: 32381497]
Adult
Aged
Antibodies, Monoclonal, Humanized
COVID-19
Female
Humans
Intensive Care Units
Length of Stay
Male
Middle Aged
Pneumonia, Viral
Propensity Score
Respiration, Artificial
Retrospective Studies
SARS-CoV-2
COVID-19 Drug Treatment
Antibodies, Monoclonal, Humanized
tocilizumab
